Table 1 Clinical characteristics for all patients.
Characteristics | Retrospective study(n = 853) | Prospective cohort study(n = 603) | ||
|---|---|---|---|---|
No. | % | No. | % | |
Age(25th–75th percentiles) (year) | ||||
Median | 44 | 45 | ||
Range | 39–50 | 41–51 | ||
Age (year) | ||||
20–30 | 36 | 4.2 | 18 | 3.0 |
30–40 | 218 | 25.6 | 126 | 20.9 |
40–50 | 403 | 47.2 | 306 | 50.6 |
50–60 | 165 | 19.3 | 131 | 21.6 |
60–70 | 31 | 3.6 | 22 | 3.6 |
Tumor size(25th–75th percentiles) (cm) | ||||
Median | 4.0 | 4.0 | ||
Range | 3.5–5.0 | 3.0–5.0 | ||
Tumor grade | ||||
G1 | 58 | 6.8 | 42 | 7.0 |
G2 | 354 | 41.5 | 242 | 40.1 |
G3 | 240 | 28.1 | 185 | 30.7 |
Undetermined | 201 | 23.6 | 134 | 22.2 |
FIGO stage | ||||
IB2 | 220 | 25.8 | 134 | 22.2 |
IIA | 265 | 31.1 | 129 | 21.4 |
IIB | 368 | 43.1 | 340 | 56.4 |
Cell type | ||||
Squamous | 756 | 88.6 | 533 | 88.4 |
Non-squamous | 91 | 10.7 | 60 | 10.0 |
Unknown | 6 | 0.7 | 10 | 1.6 |
Pathological response | ||||
OPR | 64 | 7.5 | 56 | 9.3 |
non-OPR | 789 | 92.5 | 542 | 89.9 |
Unknown | 5 | 0.8 | ||
